PATENT CLAIM ANALYSIS

Application Number: 15762993
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "236200"]

Abstract:
The present disclosure compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the TEAD transcription factor, and are useful in the treatment of diseases related to the activity of TEAD transcription factor including, e.g., cancer and other diseases.

Claim (Index 71):
The compound or pharmaceutically acceptable salt thereof of  claim 1 , wherein R H  is selected from H, C 1-6  alkyl, such as methyl, C 2-6  alkenyl, C 2-6  alkynyl, halogen, C 1-6  haloalkyl, CN, OR a1 , SR a1 , C(\u2550O)R b1 , C(\u2550O)NR c1 R d1 , C(\u2550O)OR a1 , OC(\u2550O)R b1 , OC(\u2550O)NR c1 R d1 , NR c1 R d1 , NR c1 C(\u2550O)R b1 , NR c1 C(\u2550O)NR c1 R d1 , NR c1 C(\u2550O)OR a1 , C(\u2550NR e1 )NR c1 R d1 , NR c1 C(\u2550NR e1 )NR c1 R d1 , S(\u2550O)R b1 , S(\u2550O)NR c1 R d1 , S(\u2550O) 2 R b1 , NR c1 S(\u2550O) 2 R b1  and S(\u2550O) 2 NR c1 R d1 .

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.64516
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12692078', '14795499', '15613379', '14775917', '12813148']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.772890918846487
- 35 USC 102 Novelty (BERT): 0.508195409630209
- Combined Prediction Score: 0.7464213679248591
- Mean Citation Score: 282.784528
- Max Citation Score: 299.21698
- Similarity Product: 256.5209056881308

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test